logo-loader
viewAvon Products

Avon stock up on talk of potential sale to Brazilian rival Natura

The deal could reunite Avon with its privately-held North American business, which it sold in 2015

Avon makeup
Shares of the cosmetics maker have nearly doubled in 2019

Avon Products Inc (NYSE:AVP) is discussing a possible sale with Bazillion competitor Natura & Co, the Wall Street Journal reported Friday.

Citing a person familiar with the matter, the report indicated Natura might also acquire Avon’s now-privately held North American business, stitching the cosmetics maker back together. The door-to-door makeup seller sold a majority stake in its North American arm to Cerberus Capital in 2015 and moved its headquarters to London from New York.

The stock is sitting pretty, up 11% to $3.09. Including today, shares have more than doubled since 2019 began. 

Quick facts: Avon Products

Price: - -

NYSE:AVP
Market: NYSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Feedback PLC's Tom Oakley gives clear message to NHS as Bleepa secures CE mark

Feedback PLC's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott after announcing that Bleepa, its flagship imaging-based medical communications platform, has achieved a CE Mark for Europe. Oakley says Bleepa, which allows clinicians to access medical-grade images through...

2 hours, 1 minute ago

2 min read